Piramal Pharma surges 4% after launching drug for psychiatric disorders

Piramal Pharma share price gained 3.87 per cent at Rs 252.05 a piece on the BSE in Thursday’s intraday trade. This came after Piramal Pharma’s division Piramal Critical Care (PCC) announced the US launch of Chlorpromazine Hydrochloride Injection which will be offered in 25mg/1mL and 50mg/2 mL vials .
Chlorpromazine Hydrochloride Injection is a medication primarily used to treat a range of psychiatric disorders, including schizophrenia and other psychotic conditions such as paranoia (delusions and intense feelings of worry or nervousness), mania (excessive activity and energy), anxiety, agitation, and impulsive behavior that may be dangerous.
PCC has introduced Chlorpromazine Hydrochloride, marking another addition to its growing portfolio of generic injectables. This launch follows the introduction of Edaravone IV Infusion in 2024. In 2023, PCC further expanded its portfolio with the launches of Pantoprazole Sodium for Injection, USP, and Doxycycline for Injection, USP, underscoring its commitment to providing a comprehensive range of critical care products, the company said in a statement.

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick